Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS

J Virol. 1994 Jun;68(6):4031-4. doi: 10.1128/JVI.68.6.4031-4034.1994.

Abstract

Previously we identified the highly conserved amino acids Glu-Leu-Asp-Lys-Trp-Ala (ELDKWA) on the ecto-domain of gp41 as the epitope of a neutralizing monoclonal antibody (2F5) directed against human immunodeficiency virus type 1. In the present study, the sequence defining the epitope was introduced into the loop of antigenic site B of the influenza virus hemagglutinin. The resulting chimeric virus was able to elicit ELDKWA-specific immunoglobulins G and A in antisera of mice. Moreover, the distantly related human immunodeficiency virus type 1 isolates MN, RF, and IIIB were neutralized by these antisera. These data suggest that this conserved B-cell epitope is a promising candidate for inclusion in a vaccine against AIDS. The results also show that influenza virus can be used to effectively present the antigenic structure of this B-cell epitope.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antibodies, Monoclonal
  • B-Lymphocytes / immunology
  • Base Sequence
  • Chimera / genetics
  • Chimera / immunology
  • Conserved Sequence
  • Cross Reactions
  • DNA Primers / genetics
  • DNA, Viral / genetics
  • Epitopes / genetics
  • HIV Antibodies
  • HIV Antigens / genetics*
  • HIV Envelope Protein gp41 / genetics*
  • HIV Envelope Protein gp41 / immunology*
  • HIV-1 / genetics*
  • HIV-1 / immunology*
  • Humans
  • Mice
  • Molecular Sequence Data
  • Neutralization Tests

Substances

  • Antibodies, Monoclonal
  • DNA Primers
  • DNA, Viral
  • Epitopes
  • HIV Antibodies
  • HIV Antigens
  • HIV Envelope Protein gp41